KR101005716B1 - ３－［（２－｛［４－（헥실옥시카보닐아미노－이미노-메틸）－페닐아미노］－메틸｝－１－메틸－１ｈ－벤즈이미다졸－５－카보닐）－피리딘－２－일－아미노］ 프로피온산 에틸에스테르의 경구 투여 형태 - Google Patents

３－［（２－｛［４－（헥실옥시카보닐아미노－이미노-메틸）－페닐아미노］－메틸｝－１－메틸－１ｈ－벤즈이미다졸－５－카보닐）－피리딘－２－일－아미노］ 프로피온산 에틸에스테르의 경구 투여 형태 Download PDF

Info

Publication number
KR101005716B1
KR101005716B1 KR1020047013919A KR20047013919A KR101005716B1 KR 101005716 B1 KR101005716 B1 KR 101005716B1 KR 1020047013919 A KR1020047013919 A KR 1020047013919A KR 20047013919 A KR20047013919 A KR 20047013919A KR 101005716 B1 KR101005716 B1 KR 101005716B1
Authority
KR
South Korea
Prior art keywords
methyl
acid
pharmaceutical composition
core material
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020047013919A
Other languages
English (en)
Korean (ko)
Other versions
KR20040099298A (ko
Inventor
울리히 브라운스
노르베르트 하우엘
페터 지거
Original Assignee
베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27789735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101005716(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10209985A external-priority patent/DE10209985A1/de
Priority claimed from DE2002145624 external-priority patent/DE10245624A1/de
Application filed by 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 filed Critical 베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Publication of KR20040099298A publication Critical patent/KR20040099298A/ko
Application granted granted Critical
Publication of KR101005716B1 publication Critical patent/KR101005716B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020047013919A 2002-03-07 2003-03-03 ３－［（２－｛［４－（헥실옥시카보닐아미노－이미노-메틸）－페닐아미노］－메틸｝－１－메틸－１ｈ－벤즈이미다졸－５－카보닐）－피리딘－２－일－아미노］ 프로피온산 에틸에스테르의 경구 투여 형태 Expired - Lifetime KR101005716B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10209985.5 2002-03-07
DE10209985A DE10209985A1 (de) 2002-03-07 2002-03-07 Oral zu applizierende Darreichungsform für 3-[(2-{[4-(Hexyloxycarbonylaminoimino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propinsäure-ethylester und dessen Salze
DE2002145624 DE10245624A1 (de) 2002-09-30 2002-09-30 Oral zu applizierende Darreichungsform für 3-[(2-{[4-(Hexyloxycarbonylaminoimino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2yl-amino]-propinsäure-ethylester und dessen Salze
DE10245624.0 2002-09-30
PCT/EP2003/002141 WO2003074056A1 (de) 2002-03-07 2003-03-03 Oral zu applizierende darreichungsform für 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen salze

Publications (2)

Publication Number Publication Date
KR20040099298A KR20040099298A (ko) 2004-11-26
KR101005716B1 true KR101005716B1 (ko) 2011-01-05

Family

ID=27789735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047013919A Expired - Lifetime KR101005716B1 (ko) 2002-03-07 2003-03-03 ３－［（２－｛［４－（헥실옥시카보닐아미노－이미노-메틸）－페닐아미노］－메틸｝－１－메틸－１ｈ－벤즈이미다졸－５－카보닐）－피리딘－２－일－아미노］ 프로피온산 에틸에스테르의 경구 투여 형태

Country Status (35)

Country Link
US (2) US20190231766A1 (enExample)
EP (2) EP1485094B2 (enExample)
JP (3) JP3866715B2 (enExample)
KR (1) KR101005716B1 (enExample)
CN (1) CN100528157C (enExample)
AR (2) AR042861A1 (enExample)
AT (1) ATE540943T1 (enExample)
AU (1) AU2003210400B8 (enExample)
BR (1) BRPI0306559B8 (enExample)
CA (1) CA2476054C (enExample)
CL (1) CL2009001915A1 (enExample)
CO (1) CO5611149A2 (enExample)
CY (4) CY1112796T1 (enExample)
DE (1) DE122012000047I1 (enExample)
DK (2) DK1485094T4 (enExample)
EA (1) EA009664B1 (enExample)
EC (1) ECSP045331A (enExample)
ES (2) ES2390661T5 (enExample)
HR (1) HRP20040807B1 (enExample)
IL (3) IL163863A0 (enExample)
LU (2) LU92025I2 (enExample)
ME (1) ME00325B (enExample)
MX (1) MXPA04008542A (enExample)
MY (1) MY143734A (enExample)
NO (3) NO326918B1 (enExample)
NZ (2) NZ535663A (enExample)
PE (1) PE20030889A1 (enExample)
PL (2) PL212566B1 (enExample)
PT (2) PT1485094E (enExample)
RS (1) RS52088B (enExample)
SG (1) SG146435A1 (enExample)
SI (2) SI1485094T2 (enExample)
TW (1) TWI293879B (enExample)
WO (1) WO2003074056A1 (enExample)
ZA (1) ZA200406071B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200082641A (ko) 2018-12-31 2020-07-08 주식회사 유영제약 다비가트란 에텍실레이트를 포함하는 약제학적 조성물
KR20210157693A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
KR20210157691A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
KR20210157692A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE10341043A1 (de) * 2003-09-03 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue oral zu applizierende Darreichungsform für 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen Salze
US20070298095A1 (en) * 2004-05-24 2007-12-27 Shionogi Qualicaps Co., Ltd. Surface-Modified and Solubility-Improved Hard Capsule
DE102004062864A1 (de) 2004-12-21 2006-06-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Folienbehälter
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
DE102005025728A1 (de) 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102005061624A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
AU2007276205A1 (en) * 2006-07-17 2008-01-24 Boehringer Ingelheim International Gmbh New indications for direct thrombin inhibitors in the cardiovascular field
WO2008009640A1 (en) * 2006-07-17 2008-01-24 Boehringer Ingelheim International Gmbh New paediatric indications for direct thrombin inhibitors
US20100087488A1 (en) * 2006-10-10 2010-04-08 Boehringer Ingelheim International Gmgh Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
CA2716642C (en) * 2008-03-28 2017-02-28 Boehringer Ingelheim International Gmbh Method for manufacturing acid pellets
RU2010143901A (ru) * 2008-03-28 2012-05-10 Бёрингер Ингельхайм Интернациональ Гмбх (De) Способ получения композиций дабигатрана для перорального введения
RU2529798C2 (ru) * 2008-07-14 2014-09-27 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения лекарственных соединений, содержащих дабигатран
NZ602592A (en) 2008-07-28 2014-01-31 Takeda Pharmaceutical Light irradiation resistant pharmaceutical composition
BRPI0917507A2 (pt) * 2008-08-19 2015-11-17 Boehring Ingelheim Internat Gmbh dabigatrana para a caterização cardíaca percutânea intervencionista
US20110190352A1 (en) * 2008-08-19 2011-08-04 Boehringer Ingelheim International Gmbh Use of dabigatranetexilate for treating patients with pulmonary hypertension
EP2429520A1 (en) 2009-05-14 2012-03-21 Boehringer Ingelheim International GmbH New combination therapy in treatment of oncological and fibrotic diseases
NZ597359A (en) 2009-08-24 2014-01-31 Boehringer Ingelheim Int Emergency interventions of active charcoal with dabigatran etexilate overdosing
EA201201202A1 (ru) 2010-03-01 2013-04-30 Рациофарм Гмбх Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
CA2792273A1 (en) 2010-03-08 2011-09-15 Ratiopharm Gmbh Dabigatran etexilate-containing pharmaceutical composition
US20130177652A1 (en) 2010-07-01 2013-07-11 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts
WO2012004397A1 (en) 2010-07-09 2012-01-12 Esteve Química, S.A. Intermediates and process for preparing a thrombin specific inhibitor
EP2937343A1 (en) 2010-07-09 2015-10-28 Esteve Química, S.A. Process of preparing a thrombin specific inhibitor
ES2550771T3 (es) 2010-09-27 2015-11-12 Ratiopharm Gmbh Sal de bismesilato etexilato de dabigatrán, formas en estado sólido y proceso para la preparación de las mismas
US20120301541A1 (en) * 2011-05-24 2012-11-29 Haronsky Elina Compressed core for pharmaceutical composition
CN102391250B (zh) * 2011-08-29 2013-06-19 石药集团欧意药业有限公司 一种达比加群酯化合物、制备方法及其药物组合物
EP2793864A1 (en) 2011-12-22 2014-10-29 Boehringer Ingelheim International GmbH Immediate release multi unit pellet system
US9212166B2 (en) 2012-01-20 2015-12-15 Cadila Healthcare Limited Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
WO2013110567A1 (en) 2012-01-24 2013-08-01 Boehringer Ingelheim International Gmbh Novel orally administered dabigatran formulation
PT2817000T (pt) 2012-02-21 2021-11-02 Towa Pharmaceutical Europe S L Composições farmacêuticas de dabigatrano etexilato
EP2631234A1 (en) 2012-02-23 2013-08-28 Esteve Química, S.A. Solid forms of dabigatran etexilate mesylate and processes for their preparation
WO2013144971A1 (en) 2012-03-27 2013-10-03 Cadila Healthcare Limited New solid forms of dabigatran etexilate bisulfate and mesylate and processes to prepare them
EP2834224B1 (en) 2012-04-02 2018-06-06 MSN Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
US20130345262A1 (en) 2012-06-25 2013-12-26 Boehringer Ingelheim International Gmbh Method for prevention of stroke
CA2886094A1 (en) 2012-09-28 2014-04-03 Ranbaxy Laboratories Limited Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
US20150246899A1 (en) 2012-09-28 2015-09-03 Ranbaxy Laboratories Limited Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
EP2722033A1 (en) 2012-10-19 2014-04-23 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical Compositions of Dabigatran Free Base
EP2722034B1 (en) 2012-10-19 2020-09-16 Sanovel Ilac Sanayi ve Ticaret A.S. Oral pharmaceutical formulations comprising dabigatran
EP2740471B1 (en) 2012-12-07 2015-05-27 Hexal AG Oral pharmaceutical composition comprising dabigatran etexilate
CN103127109B (zh) * 2013-02-05 2014-08-13 南京华威医药科技开发有限公司 含达比加群酯或其盐和水合物的药用组合
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
CN104414995A (zh) * 2013-09-04 2015-03-18 天津汉瑞药业有限公司 甲磺酸达比加群酯的药用组合物
EP2853260A1 (en) 2013-09-27 2015-04-01 ratiopharm GmbH Pharmaceutical preparation comprising dabigatran etexilate bismesylate
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IN2014MU01042A (enExample) 2014-03-26 2015-10-02 Cadila Healthcare Ltd
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015155281A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and proton pump inhibitors
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US10675276B2 (en) 2014-11-03 2020-06-09 Hangzhou Solipharma Co., Ltd. Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof
CN105640909B (zh) * 2014-11-14 2019-09-20 正大天晴药业集团股份有限公司 一种含有达比加群酯的药用组合物
CN106924256B (zh) * 2015-12-25 2022-08-19 深圳市药欣生物科技有限公司 药物组合物及其制备方法
WO2016107605A1 (zh) 2014-12-31 2016-07-07 昆明积大制药股份有限公司 药物组合物及其制备方法
CN105797162B (zh) * 2014-12-31 2022-10-25 昆明积大制药股份有限公司 药用辅料表面改性方法
TR201502223A2 (tr) 2015-02-25 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve dabigatranın farmasötik kombinasyonları.
CN106999434B (zh) * 2015-04-08 2020-05-22 杭州领业医药科技有限公司 一种含半胱氨酸盐酸盐的微丸及其制备方法
WO2017013106A1 (en) 2015-07-20 2017-01-26 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of dabigatran free base
CN105919962B (zh) * 2015-12-18 2019-01-18 重庆两江药物研发中心有限公司 一种达比加群酯片剂及其制备方法
WO2017111637A1 (en) 2015-12-23 2017-06-29 Zaklady Farmaceutyczne Polpharma Sa Pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof
EP3184102A1 (en) 2015-12-23 2017-06-28 Hexal AG Pharmaceutical composition of vortioxetine hydrobromide comprising an inert core formed of an acidic reacting compound
US10449195B2 (en) 2016-03-29 2019-10-22 Shenzhen Pharmacin Co., Ltd. Pharmaceutical formulation of palbociclib and a preparation method thereof
TR201606697A2 (tr) 2016-05-20 2017-12-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin yeni̇ oral farmasöti̇k formülasyonlari
EP3332771A1 (en) 2016-12-07 2018-06-13 Sanovel Ilac Sanayi ve Ticaret A.S. Multilayered tablet compositions of dabigatran
TR201617984A2 (tr) 2016-12-07 2018-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin farmasöti̇k kompozi̇syonlari
WO2018122262A1 (en) 2016-12-28 2018-07-05 Sanovel Ilac Sanayi Ve Ticaret A.S. Bilayer tablet formulations of dabigatran etexilate
JP2018184375A (ja) 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2018229784A1 (en) * 2017-06-14 2018-12-20 Natco Pharma Limited Pharmaceutical compositions of dabigatran
CN109125274A (zh) * 2017-06-28 2019-01-04 上海美悦生物科技发展有限公司 注射用苯并咪唑类药用酸组合物及其制备方法和用途
TR201722186A2 (tr) 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin farmasöti̇k kompozi̇syonlari
TR201722323A2 (tr) 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari
TR201722353A2 (tr) 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatran eteksi̇lat i̇çeren oral uygulama i̇çi̇n farmasöti̇k formülasyon
TR201722630A2 (enExample) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
CN110339193B (zh) 2018-04-04 2022-04-29 上海汉都医药科技有限公司 含达比加群酯的药物组合物及其制备方法
EP3771465A1 (en) 2019-08-01 2021-02-03 Zaklady Farmaceutyczne Polpharma SA Pharmaceutical composition comprising dabigatran etexilate
CN114306245A (zh) 2020-09-29 2022-04-12 深圳市药欣生物科技有限公司 无定形固体分散体的药物组合物及其制备方法
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
CN115227663B (zh) * 2021-04-22 2023-12-12 石药集团恩必普药业有限公司 一种甲磺酸达比加群酯胶囊及其制备方法
BR112023025430A2 (pt) * 2021-06-04 2024-02-20 Zim Laboratories Ltd Composições farmacêuticas inovadoras que compreendem etexilato de dabigatrana ou sal do mesmo
WO2023139243A1 (en) 2022-01-21 2023-07-27 Adamed Pharma S.A A process for preparation of tartaric acid cores for dabigatran pellets and the pellets containing dabigatran
GR1010399B (el) * 2022-04-05 2023-02-03 Φαρματεν Α.Β.Ε.Ε., Φαρμακευτικο σκευασμα που περιλαμβανει εναν αντιπηκτικο παραγοντα και μεθοδος παραγωγης αυτου
WO2024175037A1 (zh) * 2023-02-21 2024-08-29 广州玻思韬控释药业有限公司 达比加群酯或其药物可接受的盐的微丸
WO2024217830A1 (en) 2023-03-30 2024-10-24 Adamed Pharma S.A A process for preparation of hard capsules filled with dabigatran pellets

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100619458B1 (ko) * 1997-02-18 2006-09-08 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 이치환된 비사이클릭 헤테로사이클, 이의 제조방법 및 이를 함유하는 약제학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
JPS58134033A (ja) * 1982-02-02 1983-08-10 Fujisawa Pharmaceut Co Ltd 医薬組成物
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100619458B1 (ko) * 1997-02-18 2006-09-08 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 이치환된 비사이클릭 헤테로사이클, 이의 제조방법 및 이를 함유하는 약제학적 조성물

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200082641A (ko) 2018-12-31 2020-07-08 주식회사 유영제약 다비가트란 에텍실레이트를 포함하는 약제학적 조성물
KR20210157693A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
KR20210157691A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
KR20210157692A (ko) 2020-06-22 2021-12-29 한국유나이티드제약 주식회사 다비가트란 에텍실레이트를 포함하는 경구용 약학조성물

Also Published As

Publication number Publication date
EP1870100A1 (de) 2007-12-26
EA009664B1 (ru) 2008-02-28
ES2380704T9 (es) 2013-07-24
AU2003210400A1 (en) 2003-09-16
HRP20040807A2 (en) 2005-02-28
CY1113158T1 (el) 2015-08-05
NO2013001I2 (no) 2014-09-01
RS79204A (sr) 2007-02-05
PL394601A1 (pl) 2011-07-18
ES2380704T3 (es) 2012-05-17
DK1870100T3 (da) 2012-05-14
HRP20040807B1 (hr) 2014-11-21
CY2012031I1 (el) 2015-08-05
NO20042361D0 (no) 2004-06-07
TWI293879B (en) 2008-03-01
EA200401136A1 (ru) 2005-04-28
JP4953727B2 (ja) 2012-06-13
NO2013001I1 (no) 2013-02-11
EP1485094A1 (de) 2004-12-15
CA2476054A1 (en) 2003-09-12
AU2003210400B2 (en) 2008-08-07
JP3866715B2 (ja) 2007-01-10
HK1078792A1 (en) 2006-03-24
EP1870100B1 (de) 2012-01-11
PT1870100E (pt) 2012-04-17
US20200085807A1 (en) 2020-03-19
NZ535663A (en) 2006-06-30
EP1485094B1 (de) 2012-07-04
NO20042361L (no) 2004-06-07
BRPI0306559B8 (pt) 2021-05-25
ATE540943T1 (de) 2012-01-15
BRPI0306559B1 (pt) 2021-05-18
JP2007056018A (ja) 2007-03-08
CN100528157C (zh) 2009-08-19
RS52088B (sr) 2012-06-30
CL2009001915A1 (es) 2010-02-12
PL210862B1 (pl) 2012-03-30
IL163863A (en) 2013-02-28
ECSP045331A (es) 2006-04-19
KR20040099298A (ko) 2004-11-26
NO332209B1 (no) 2012-07-30
CY1112796T1 (el) 2015-08-05
CN1638771A (zh) 2005-07-13
LU92025I2 (fr) 2012-08-20
CY2012020I1 (el) 2015-08-05
PE20030889A1 (es) 2003-12-10
WO2003074056A1 (de) 2003-09-12
CY2012020I2 (el) 2015-08-05
AR042861A1 (es) 2005-07-06
SI1485094T1 (sl) 2012-10-30
IL163863A0 (en) 2005-12-18
AR072385A2 (es) 2010-08-25
PT1485094E (pt) 2012-10-09
DK1485094T4 (da) 2020-06-22
SI1485094T2 (sl) 2020-08-31
IL209368A0 (en) 2011-01-31
DE122012000047I1 (de) 2012-09-13
LU92117I2 (fr) 2013-02-19
MEP50708A (en) 2011-02-10
PL212566B1 (pl) 2012-10-31
SI1870100T1 (sl) 2012-05-31
NO20081304L (no) 2004-06-07
ME00325B (me) 2011-05-10
JP2006328081A (ja) 2006-12-07
IL209368A (en) 2012-10-31
DK1485094T3 (da) 2012-10-15
MY143734A (en) 2011-07-15
NO326918B1 (no) 2009-03-16
ZA200406071B (en) 2005-11-30
EP1485094B2 (de) 2020-03-25
JP2005519099A (ja) 2005-06-30
AU2003210400B8 (en) 2008-09-25
CA2476054C (en) 2011-11-08
CY2012031I2 (el) 2015-08-05
US20190231766A1 (en) 2019-08-01
ES2390661T3 (es) 2012-11-15
ES2390661T5 (es) 2020-12-04
CO5611149A2 (es) 2006-02-28
TW200306188A (en) 2003-11-16
MXPA04008542A (es) 2004-12-06
SG146435A1 (en) 2008-10-30
PL370517A1 (en) 2005-05-30
BR0306559A (pt) 2004-11-30
NZ546367A (en) 2008-08-29

Similar Documents

Publication Publication Date Title
KR101005716B1 (ko) ３－［（２－｛［４－（헥실옥시카보닐아미노－이미노-메틸）－페닐아미노］－메틸｝－１－메틸－１ｈ－벤즈이미다졸－５－카보닐）－피리딘－２－일－아미노］ 프로피온산 에틸에스테르의 경구 투여 형태
US9925174B2 (en) Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof
US20050095293A1 (en) Administration form for the oral application of poorly soluble drugs
US20130216617A1 (en) Pharmaceutical compositions of (r)-lansoprazole
JP2015500853A (ja) 即時放出マルチユニットペレットシステム
CN101632668A (zh) 口服药物组合物
HK1135337A (en) Orally administered pharmaceutical composition
HK1078792B (en) Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered orally

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040906

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20080303

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100223

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20101129

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20101228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20101229

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20131220

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20131220

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20141219

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20141219

Start annual number: 5

End annual number: 5

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150604

Appeal identifier: 2015100000937

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000935

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000934

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150707

Appeal identifier: 2015100000932

Appeal kind category: Invalidation

Request date: 20150313

Appeal identifier: 2015100000930

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150506

Appeal identifier: 2015100000929

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150727

Appeal identifier: 2015100000928

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150609

Appeal identifier: 2015100000926

Appeal kind category: Invalidation

Request date: 20150313

Appeal identifier: 2015100000924

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000923

Patent event date: 20150313

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20101228

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20150330

Appeal identifier: 2015100000921

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001607

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20151030

Appeal identifier: 2015100001560

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001539

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001532

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20150721

Appeal identifier: 2015100001528

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001526

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20150812

Appeal identifier: 2015100001489

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001488

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001487

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001486

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001448

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001421

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001420

Appeal kind category: Invalidation

Request date: 20150327

Appeal identifier: 2015100001419

Appeal kind category: Invalidation

Request date: 20150327

Appeal identifier: 2015100001418

Patent event date: 20150327

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20101228

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001368

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20160215

Appeal identifier: 2015100001629

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20160215

Appeal identifier: 2015100001628

Patent event date: 20150328

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20101228

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20160621

Appeal identifier: 2015100001622

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150330

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000921

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150330

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150506

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000929

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150506

J501 Disposition of invalidation of trial
PJ0501 Disposition of invalidation of trial

Appeal kind category: Invalidation

Request date: 20150313

Appeal identifier: 2015100000930

Appeal kind category: Invalidation

Request date: 20150313

Appeal identifier: 2015100000924

J121 Written withdrawal of request for trial
J501 Disposition of invalidation of trial
PJ0501 Disposition of invalidation of trial

Appeal kind category: Invalidation

Request date: 20150327

Appeal identifier: 2015100001419

Appeal kind category: Invalidation

Request date: 20150327

Appeal identifier: 2015100001418

PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150604

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000937

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150604

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150609

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000926

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150609

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150707

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000932

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150707

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150721

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001528

Request date: 20150327

Appeal kind category: Invalidation

Decision date: 20150721

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150727

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100000928

Request date: 20150313

Appeal kind category: Invalidation

Decision date: 20150727

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20150812

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001489

Request date: 20150327

Appeal kind category: Invalidation

Decision date: 20150812

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20151030

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001560

Request date: 20150327

Appeal kind category: Invalidation

Decision date: 20151030

FPAY Annual fee payment

Payment date: 20151218

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20151218

Start annual number: 6

End annual number: 6

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Appeal identifier: 2015100001629

Request date: 20150328

Appeal kind category: Invalidation

Decision date: 20160215

Patent event code: PJ12011R01D

Patent event date: 20160215

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2015100001628

Request date: 20150328

Appeal kind category: Invalidation

Decision date: 20160215

J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20150313

Effective date: 20160621

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20150328

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100000935; TRIAL DECISION FOR INVALIDATION REQUESTED 20150313

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001368; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001526; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100000923; TRIAL DECISION FOR INVALIDATION REQUESTED 20150313

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001622; TRIAL DECISION FOR INVALIDATION REQUESTED 20150328

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001420; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001532; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001488; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001607; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001448; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001487; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100000934; TRIAL DECISION FOR INVALIDATION REQUESTED 20150313

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001421; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001486; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

Free format text: TRIAL NUMBER: 2015100001539; TRIAL DECISION FOR INVALIDATION REQUESTED 20150327

Effective date: 20160621

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20150328

Decision date: 20160621

Appeal identifier: 2015100001622

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001607

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001539

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001532

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001526

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001488

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001487

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001486

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001448

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001421

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001420

Appeal kind category: Invalidation

Request date: 20150327

Decision date: 20160621

Appeal identifier: 2015100001368

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000935

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000934

Patent event code: PJ13011S05D

Patent event date: 20160621

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Appeal kind category: Invalidation

Request date: 20150313

Decision date: 20160621

Appeal identifier: 2015100000923

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: TRIAL NUMBER: 2016200005484; INVALIDATION

PJ2001 Appeal

Patent event date: 20160621

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S05I

Appeal kind category: Invalidation

Decision date: 20170217

Appeal identifier: 2016200005484

Request date: 20160721

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: TRIAL NUMBER: 2016200005576; INVALIDATION

Free format text: TRIAL NUMBER: 2016200005538; INVALIDATION

Free format text: TRIAL NUMBER: 2016200005569; INVALIDATION

Free format text: TRIAL NUMBER: 2016200005552; INVALIDATION

PJ2001 Appeal

Appeal kind category: Invalidation

Decision date: 20170217

Appeal identifier: 2016200005576

Request date: 20160722

Appeal kind category: Invalidation

Decision date: 20170217

Appeal identifier: 2016200005569

Request date: 20160722

Appeal kind category: Invalidation

Decision date: 20170217

Appeal identifier: 2016200005552

Request date: 20160722

Patent event date: 20160621

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S05I

Appeal kind category: Invalidation

Decision date: 20170217

Appeal identifier: 2016200005538

Request date: 20160722

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170919

Request date: 20160802

Appeal identifier: 2016100002290

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170919

Request date: 20160802

Appeal identifier: 2016100002289

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170919

Request date: 20160802

Appeal identifier: 2016100002288

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170919

Request date: 20160802

Appeal identifier: 2016100002287

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20160802

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170919

Request date: 20160802

Appeal identifier: 2016100002286

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170919

Request date: 20160816

Appeal identifier: 2016100002484

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20160816

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170919

Request date: 20160816

Appeal identifier: 2016100002478

Appeal kind category: Confirmation of the scope of right_defensive

PG1701 Publication of correction

Publication date: 20171130

PG1701 Publication of correction

Publication date: 20171130

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170920

Request date: 20161102

Appeal identifier: 2016100003473

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170920

Request date: 20161102

Appeal identifier: 2016100003471

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20161102

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170920

Request date: 20161102

Appeal identifier: 2016100003468

Appeal kind category: Confirmation of the scope of right_defensive

PG1701 Publication of correction

Publication date: 20171130

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20161110

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170920

Request date: 20161110

Appeal identifier: 2016100003562

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20161115

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170920

Request date: 20161115

Appeal identifier: 2016100003594

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170920

Request date: 20161123

Appeal identifier: 2016100003708

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20161123

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170920

Request date: 20161123

Appeal identifier: 2016100003698

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20161124

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170901

Request date: 20161124

Appeal identifier: 2016100003719

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170901

Request date: 20161207

Appeal identifier: 2016100003916

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20161219

Request date: 20161207

Appeal identifier: 2016100003913

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170920

Request date: 20161207

Appeal identifier: 2016100003911

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20161207

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170920

Request date: 20161207

Appeal identifier: 2016100003910

Appeal kind category: Confirmation of the scope of right_defensive

FPAY Annual fee payment

Payment date: 20161216

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20161216

Start annual number: 7

End annual number: 7

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20161219

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2016100003913

Request date: 20161207

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20161219

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20170126

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170824

Request date: 20170126

Appeal identifier: 2017100000257

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20170824

Request date: 20170310

Appeal identifier: 2017100000762

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20170310

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20170830

Request date: 20170310

Appeal identifier: 2017100000760

Appeal kind category: Confirmation of the scope of right_defensive

PJ2002 Appeal before the supreme court

Request date: 20170315

Appeal identifier: 2017300000691

Appeal kind category: Invalidation

Decision date: 20170620

Request date: 20170315

Appeal identifier: 2017300000684

Appeal kind category: Invalidation

Decision date: 20170620

Request date: 20170315

Appeal identifier: 2017300000677

Appeal kind category: Invalidation

Decision date: 20170620

Request date: 20170315

Appeal identifier: 2017300000660

Appeal kind category: Invalidation

Decision date: 20170620

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event date: 20160621

Patent event code: PJ20021S05I

Request date: 20170315

Appeal identifier: 2017300000653

Appeal kind category: Invalidation

Decision date: 20170620

PJ1302 Judgment (patent court)

Request date: 20160722

Decision date: 20170217

Appeal identifier: 2016200005576

Appeal kind category: Invalidation

Request date: 20160722

Decision date: 20170217

Appeal identifier: 2016200005569

Appeal kind category: Invalidation

Request date: 20160722

Decision date: 20170217

Appeal identifier: 2016200005552

Appeal kind category: Invalidation

Request date: 20160722

Decision date: 20170217

Appeal identifier: 2016200005538

Appeal kind category: Invalidation

Patent event date: 20170428

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20160721

Decision date: 20170217

Appeal identifier: 2016200005484

Appeal kind category: Invalidation

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20171011

Request date: 20170512

Appeal identifier: 2017100001467

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20171011

Request date: 20170512

Appeal identifier: 2017100001466

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20171011

Request date: 20170512

Appeal identifier: 2017100001465

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20170512

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20171011

Request date: 20170512

Appeal identifier: 2017100001464

Appeal kind category: Confirmation of the scope of right_defensive

J221 Remand (intellectual property tribunal)

Free format text: TRIAL NUMBER: 2017130000113; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION

Free format text: TRIAL NUMBER: 2017130000110; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION

Free format text: TRIAL NUMBER: 2017130000111; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION

Free format text: TRIAL NUMBER: 2017130000112; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION

J303 Written judgement (supreme court)

Free format text: TRIAL NUMBER: 2017300000660; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170315

Effective date: 20170620

Free format text: TRIAL NUMBER: 2017300000677; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170315

Effective date: 20170620

Free format text: TRIAL NUMBER: 2017300000691; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170315

Effective date: 20170620

Free format text: TRIAL NUMBER: 2017300000653; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170315

Effective date: 20170620

PJ1303 Judgment (supreme court)

Decision date: 20170620

Appeal kind category: Invalidation

Request date: 20170315

Appeal identifier: 2017300000691

Decision date: 20170620

Appeal kind category: Invalidation

Request date: 20170315

Appeal identifier: 2017300000677

Decision date: 20170620

Appeal kind category: Invalidation

Request date: 20170315

Appeal identifier: 2017300000660

Comment text: Written Judgment (Supreme Court)

Patent event date: 20170720

Patent event code: PJ13031S01D

Decision date: 20170620

Appeal kind category: Invalidation

Request date: 20170315

Appeal identifier: 2017300000653

PJ2201 Remand (intellectual property tribunal)

Request date: 20170720

Appeal kind category: Invalidation

Appeal identifier: 2017130000113

Decision date: 20170811

Request date: 20170720

Appeal kind category: Invalidation

Appeal identifier: 2017130000112

Decision date: 20170811

Request date: 20170720

Appeal kind category: Invalidation

Appeal identifier: 2017130000111

Decision date: 20170811

Request date: 20170720

Appeal kind category: Invalidation

Appeal identifier: 2017130000110

Decision date: 20170811

J221 Remand (intellectual property tribunal)

Free format text: TRIAL NUMBER: 2017130000117; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION

J303 Written judgement (supreme court)

Free format text: TRIAL NUMBER: 2017300000684; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170315

Effective date: 20170620

PJ1303 Judgment (supreme court)

Comment text: Written Judgment (Supreme Court)

Patent event date: 20170725

Patent event code: PJ13031S01D

Decision date: 20170620

Appeal kind category: Invalidation

Request date: 20170315

Appeal identifier: 2017300000684

PJ2201 Remand (intellectual property tribunal)

Request date: 20170725

Appeal kind category: Invalidation

Appeal identifier: 2017130000117

Decision date: 20170811

J301 Trial decision

Free format text: TRIAL NUMBER: 2017130000113; TRIAL DECISION FOR INVALIDATION REQUESTED 20170720

Effective date: 20170811

Free format text: TRIAL NUMBER: 2017130000111; TRIAL DECISION FOR INVALIDATION REQUESTED 20170720

Effective date: 20170811

Free format text: TRIAL NUMBER: 2017130000110; TRIAL DECISION FOR INVALIDATION REQUESTED 20170720

Effective date: 20170811

Free format text: TRIAL NUMBER: 2017130000112; TRIAL DECISION FOR INVALIDATION REQUESTED 20170720

Effective date: 20170811

Free format text: TRIAL NUMBER: 2017130000117; TRIAL DECISION FOR INVALIDATION REQUESTED 20170725

Effective date: 20170811

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20170725

Decision date: 20170811

Appeal identifier: 2017130000117

Appeal kind category: Invalidation

Request date: 20170720

Decision date: 20170811

Appeal identifier: 2017130000113

Appeal kind category: Invalidation

Request date: 20170720

Decision date: 20170811

Appeal identifier: 2017130000112

Appeal kind category: Invalidation

Request date: 20170720

Decision date: 20170811

Appeal identifier: 2017130000111

Patent event code: PJ13011S09D

Patent event date: 20170811

Comment text: Trial Decision on Final Judgment on Revocation

Appeal kind category: Invalidation

Request date: 20170720

Decision date: 20170811

Appeal identifier: 2017130000110

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Appeal identifier: 2017100000762

Request date: 20170310

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170824

Patent event code: PJ12011R01D

Patent event date: 20170824

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2017100000257

Request date: 20170126

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170824

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20170830

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2017100000760

Request date: 20170310

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170830

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Appeal identifier: 2016100003916

Request date: 20161207

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170901

Patent event code: PJ12011R01D

Patent event date: 20170901

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2016100003719

Request date: 20161124

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20170901

J301 Trial decision

Free format text: TRIAL NUMBER: 2016100002288; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160802

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002286; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160802

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002287; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160802

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002478; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160816

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002290; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160802

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002484; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160816

Effective date: 20170919

Free format text: TRIAL NUMBER: 2016100002289; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160802

Effective date: 20170919

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160816

Decision date: 20170919

Appeal identifier: 2016100002484

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160816

Decision date: 20170919

Appeal identifier: 2016100002478

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160802

Decision date: 20170919

Appeal identifier: 2016100002290

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160802

Decision date: 20170919

Appeal identifier: 2016100002289

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160802

Decision date: 20170919

Appeal identifier: 2016100002288

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160802

Decision date: 20170919

Appeal identifier: 2016100002287

Patent event code: PJ13011S02D

Patent event date: 20170919

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160802

Decision date: 20170919

Appeal identifier: 2016100002286

J301 Trial decision

Free format text: TRIAL NUMBER: 2016100003562; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161110

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003708; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161123

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003594; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161115

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003473; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161102

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003471; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161102

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003910; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161207

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003698; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161123

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003468; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161102

Effective date: 20170920

Free format text: TRIAL NUMBER: 2016100003911; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161207

Effective date: 20170920

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161207

Decision date: 20170920

Appeal identifier: 2016100003911

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161207

Decision date: 20170920

Appeal identifier: 2016100003910

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161123

Decision date: 20170920

Appeal identifier: 2016100003708

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161123

Decision date: 20170920

Appeal identifier: 2016100003698

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161115

Decision date: 20170920

Appeal identifier: 2016100003594

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161110

Decision date: 20170920

Appeal identifier: 2016100003562

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161102

Decision date: 20170920

Appeal identifier: 2016100003473

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161102

Decision date: 20170920

Appeal identifier: 2016100003471

Patent event code: PJ13011S02D

Patent event date: 20170920

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161102

Decision date: 20170920

Appeal identifier: 2016100003468

J301 Trial decision

Free format text: TRIAL NUMBER: 2017100001464; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170512

Effective date: 20171011

Free format text: TRIAL NUMBER: 2017100001465; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170512

Effective date: 20171011

Free format text: TRIAL NUMBER: 2017100001466; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170512

Effective date: 20171011

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20170512

Decision date: 20171011

Appeal identifier: 2017100001467

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20170512

Decision date: 20171011

Appeal identifier: 2017100001466

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20170512

Decision date: 20171011

Appeal identifier: 2017100001465

Patent event code: PJ13011S02D

Patent event date: 20171011

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20170512

Decision date: 20171011

Appeal identifier: 2017100001464

PG1701 Publication of correction

Publication date: 20171130

PR1001 Payment of annual fee

Payment date: 20171215

Start annual number: 8

End annual number: 8

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20180810

Request date: 20180209

Appeal identifier: 2018100000416

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20180810

Request date: 20180209

Appeal identifier: 2018100000415

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20180810

Request date: 20180209

Appeal identifier: 2018100000414

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20180810

Request date: 20180209

Appeal identifier: 2018100000413

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20180209

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20180810

Request date: 20180209

Appeal identifier: 2018100000410

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20180226

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20101228

Comment text: Registration of Establishment

Decision date: 20180810

Request date: 20180226

Appeal identifier: 2018100000530

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2018100000415; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180209

Effective date: 20180810

Free format text: TRIAL NUMBER: 2018100000414; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180209

Effective date: 20180810

Free format text: TRIAL NUMBER: 2018100000416; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180209

Effective date: 20180810

Free format text: TRIAL NUMBER: 2018100000413; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180209

Effective date: 20180810

Free format text: TRIAL NUMBER: 2018100000410; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180209

Effective date: 20180810

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180226

Decision date: 20180810

Appeal identifier: 2018100000530

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180209

Decision date: 20180810

Appeal identifier: 2018100000416

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180209

Decision date: 20180810

Appeal identifier: 2018100000415

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180209

Decision date: 20180810

Appeal identifier: 2018100000414

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180209

Decision date: 20180810

Appeal identifier: 2018100000413

Patent event code: PJ13011S02D

Patent event date: 20180810

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20180209

Decision date: 20180810

Appeal identifier: 2018100000410

FPAY Annual fee payment

Payment date: 20181220

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20181220

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20191220

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20201218

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20211217

Start annual number: 12

End annual number: 12

PC1801 Expiration of term

Termination date: 20230903

Termination category: Expiration of duration